PROCEPT BioRobotics (PRCT) Total Non-Current Liabilities (2020 - 2026)
PROCEPT BioRobotics has reported Total Non-Current Liabilities over the past 7 years, most recently at $139.3 million for Q1 2026.
- Quarterly Total Non-Current Liabilities rose 7.22% to $139.3 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $139.3 million through Mar 2026, up 7.22% year-over-year, with the annual reading at $142.1 million for FY2025, 8.06% up from the prior year.
- Total Non-Current Liabilities was $139.3 million for Q1 2026 at PROCEPT BioRobotics, down from $142.1 million in the prior quarter.
- Over five years, Total Non-Current Liabilities peaked at $142.1 million in Q4 2025 and troughed at $68.0 million in Q1 2022.
- The 5-year median for Total Non-Current Liabilities is $122.1 million (2024), against an average of $117.2 million.
- Year-over-year, Total Non-Current Liabilities soared 61.43% in 2022 and then fell 1.33% in 2025.
- A 5-year view of Total Non-Current Liabilities shows it stood at $110.5 million in 2022, then grew by 11.74% to $123.4 million in 2023, then grew by 6.5% to $131.5 million in 2024, then grew by 8.06% to $142.1 million in 2025, then fell by 1.96% to $139.3 million in 2026.
- Per Business Quant, the three most recent readings for PRCT's Total Non-Current Liabilities are $139.3 million (Q1 2026), $142.1 million (Q4 2025), and $130.7 million (Q3 2025).